Company accused of false Medicaid claims for Xenaderm, which lacked FDA approval Pennsylvania reached a multi-million-dollar settlement with Healthpoint Ltd and DFB Pharmaceuticals to resolve allegations that Healthpoint caused false claims to be submitted to Medicaid for an unapproved drug, state Attorney General Kathleen G. Kane announced Monday. Pennsylvania’s settlement, which will return nearly $2 … Continue reading Pa. to receive nearly $2 million in drug settlement